Home » Diatos and Servier Announce Oncology Research Collaboration
Diatos and Servier Announce Oncology Research Collaboration
Diatos S.A., a Paris-based privately held biopharmaceutical company, and Servier, France's largest privately owned pharmaceutical company, announced a research collaboration involving FTE support and a license option to apply the Diatos Vectocell technology to Servier's oncology research program in order to enhance the efficacy and safety of a Servier small molecule drug candidate.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May